Cargando…
State of the Art of Pharmacological Activators of p53 in Ocular Malignancies
SIMPLE SUMMARY: Ocular malignancies encompass a broad range of disorders that affect the eyelids, orbit, and eye and have significant impacts for national healthcare systems. Due to its exposure to various stressors, the eye is an anatomical site susceptible to cellular toxicity and tissue damage, w...
Autores principales: | Casciano, Fabio, Zauli, Enrico, Busin, Massimo, Caruso, Lorenzo, AlMesfer, Saleh, Al-Swailem, Samar, Zauli, Giorgio, Yu, Angeli Christy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377487/ https://www.ncbi.nlm.nih.gov/pubmed/37509256 http://dx.doi.org/10.3390/cancers15143593 |
Ejemplares similares
-
MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma
por: Romani, Arianna, et al.
Publicado: (2022) -
The role of the mTOR pathway in diabetic retinopathy
por: Casciano, Fabio, et al.
Publicado: (2022) -
Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation
por: Zauli, Giorgio, et al.
Publicado: (2022) -
Microsporidial Stromal Keratitis in Post-Keratoplasty Eyes
por: Spena, Rossella, et al.
Publicado: (2023) -
p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics)
por: Milani, Daniela, et al.
Publicado: (2022)